Nanalysis Scientific Corp.
NSCIF
$0.12
$0.00-1.63%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -6.24% | -15.92% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.24% | -15.92% | |||
| Cost of Revenue | -4.53% | -5.18% | |||
| Gross Profit | -11.21% | -36.70% | |||
| SG&A Expenses | 13.58% | 1.91% | |||
| Depreciation & Amortization | 19.20% | -22.85% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.58% | -4.87% | |||
| Operating Income | -79.30% | -410.11% | |||
| Income Before Tax | -78.34% | 83.65% | |||
| Income Tax Expenses | -166.67% | 291.19% | |||
| Earnings from Continuing Operations | -68.41% | 82.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -68.41% | 82.89% | |||
| EBIT | -79.30% | -410.11% | |||
| EBITDA | -91.21% | -247.62% | |||
| EPS Basic | -68.75% | 83.01% | |||
| Normalized Basic EPS | -81.25% | -84.62% | |||
| EPS Diluted | -81.25% | 83.01% | |||
| Normalized Diluted EPS | -81.25% | -84.62% | |||
| Average Basic Shares Outstanding | 0.28% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.28% | 0.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||